机构：[1]Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation (ZP, MY, and KH are co-first authors), Hannover Medical School, Hannover, Germany[2]Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany[3]Institute of Pathology, Hannover Medical School, Hannover, Germany[4]Department of Human Genetics, Hannover Medical School, Hannover, Germany[5]Institute of Cell Biochemistry, Hannover Medical School, Hannover, Germany[6]Department of Oncology, Hematology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany[7]Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属同济医院[8]The University Children's Hospital Tuebingen, Tuebingen, Germany[9]Department of Hematology, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, CHN
第一作者机构：[1]Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation (ZP, MY, and KH are co-first authors), Hannover Medical School, Hannover, Germany
共同第一作者：
推荐引用方式(GB/T 7714)：
Pan Zengkai,Yang Min,Huang Kezhi,et al.Synergy between FLT3-ITD and p53 Haploinsufficiency or Loss in the Development of Acute Myeloid Leukemia[J].BLOOD.2018,132:doi:10.1182/blood-2018-99-110770.
APA：
Pan, Zengkai,Yang, Min,Huang, Kezhi,Buesche, Guntram,Goehring, Gudrun...&Li, Zhixiong.(2018).Synergy between FLT3-ITD and p53 Haploinsufficiency or Loss in the Development of Acute Myeloid Leukemia.BLOOD,132,
MLA：
Pan, Zengkai,et al."Synergy between FLT3-ITD and p53 Haploinsufficiency or Loss in the Development of Acute Myeloid Leukemia".BLOOD 132.(2018)
医学